Logo.png
Obesity Pipeline: Insights into Key Pharma Companies, Clinical Trials, Drug Pipeline, R&D and Emerging Obesity Pipeline Trends
August 19, 2021 20:00 ET | DelveInsight Business Research LLP
Los Angeles, USA, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Obesity Pipeline: Insights into Key Pharma Companies, Clinical Trials, Drug Pipeline, R&D and Emerging Obesity Pipeline Trends The Obesity...
Nature Zen Logo.jpg
Nature Zen is Delighted to Launch Their High Quality Organic Plant-Based Protein on the US Market
August 13, 2021 10:00 ET | Nature Zen
ESSEX JUNCTION, Vt., Aug. 13, 2021 (GLOBE NEWSWIRE) -- For those who remember, 20 years ago being a vegetarian or sensitive to a plant-based diet was quite a challenge when dining out, grocery...
Stop&Shop_LOGO.jpg
Stop & Shop Becomes First Ever Grocery Retailer to Participate in the National Academy of Sciences’ Roundtable on Obesity Solutions
July 08, 2021 15:21 ET | Stop and Shop
QUINCY, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Furthering its commitment to health and sustainability in the communities it serves, Stop & Shop announced today its participation in the...
160223 logo Adocia avec homme qui marche.jpg
Adocia Expands Clinical Development to Obesity with Patent Applications on Short-Acting Multihormonal Combinations Administered by Pumps
May 26, 2021 01:30 ET | Adocia SA
Three patent families have been filed to cover novel hormonal combinations: pramlintide-exenatide and glucagon-exenatide – both combinations demonstrated promising effects in obesity...
泵给药短效多激素组合专利申请将Adocia临床研究扩展到肥胖症领域
May 26, 2021 01:30 ET | Adocia SA
已申请三项专利系列涵盖新型激素组合:普兰林肽-艾塞那肽和胰高血糖素-艾塞那肽——两种组合在肥胖症治疗中均显示出令人鼓舞的效果通过泵输注短效激素可以增强患者授权,使患者可以优化治疗的获益/风险比这些配方也可以用于治疗其他代谢性疾病,例如NASH(非酒精性脂肪性肝炎),2型糖尿病或神经退行性疾病 里昂, May 26, 2021 (GLOBE NEWSWIRE) -- Adocia...
Clinical Highlights: 2021 CMHC Spring Cardiometabolic Health Congress
April 22, 2021 16:32 ET | Cardiometabolic Health Congress
Boca Raton, FL, April 22, 2021 (GLOBE NEWSWIRE) -- Clinical Highlights: 2021 CMHC Spring Cardiometabolic Health Congress Top Experts Convene to Discuss the Syndemic of COVID-19 &...
Global Liver Institute Offering Multilingual Materials and Grants for International NASH Day on June 10
March 04, 2021 09:24 ET | Global Liver Institute
Washington, DC, March 04, 2021 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) is pleased to announce that the 2021 International NASH Day (#NASHday) will be held on June 10, 2021, with the theme,...
thumbnail_Pan-Biome-logo.png
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome
February 24, 2021 10:00 ET | Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
Why Did I Eat That? Obesity and the Neuroscience of Food Craving - A Free Webinar from the Brain & Behavior Research Foundation
October 05, 2020 09:00 ET | Brain & Behavior Research Foundation
New York, Oct. 05, 2020 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation is hosting a free webinar “Why Did I Eat That? Obesity and the Neuroscience of Food Craving” on Tuesday,...
NBGH_logo_12122019_a.jpg
Northeast Business Group on Health Releases Employer Guide to Evaluate Weight Management Programs Amid COVID-19
September 23, 2020 09:15 ET | Northeast Business Group on Health
NEW YORK, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Northeast Business Group on Health (NEBGH) has released “Workplace Weight Management in the New Normal,” a new guide to help HR and benefits leaders...